PubMed:23558898
Annnotations
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":151,"end":162},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":163,"end":405},"obj":"Sentence"},{"id":"TextSentencer_T4","span":{"begin":406,"end":628},"obj":"Sentence"},{"id":"TextSentencer_T5","span":{"begin":629,"end":637},"obj":"Sentence"},{"id":"TextSentencer_T6","span":{"begin":638,"end":796},"obj":"Sentence"},{"id":"TextSentencer_T7","span":{"begin":797,"end":927},"obj":"Sentence"},{"id":"TextSentencer_T8","span":{"begin":928,"end":1034},"obj":"Sentence"},{"id":"TextSentencer_T9","span":{"begin":1035,"end":1043},"obj":"Sentence"},{"id":"TextSentencer_T10","span":{"begin":1044,"end":1214},"obj":"Sentence"},{"id":"TextSentencer_T11","span":{"begin":1215,"end":1367},"obj":"Sentence"},{"id":"TextSentencer_T12","span":{"begin":1368,"end":1470},"obj":"Sentence"},{"id":"TextSentencer_T13","span":{"begin":1471,"end":1556},"obj":"Sentence"},{"id":"TextSentencer_T14","span":{"begin":1557,"end":1629},"obj":"Sentence"},{"id":"TextSentencer_T15","span":{"begin":1630,"end":1757},"obj":"Sentence"},{"id":"TextSentencer_T16","span":{"begin":1758,"end":1770},"obj":"Sentence"},{"id":"TextSentencer_T17","span":{"begin":1771,"end":1893},"obj":"Sentence"},{"id":"TextSentencer_T18","span":{"begin":1894,"end":2090},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":150},"obj":"Sentence"},{"id":"T2","span":{"begin":151,"end":162},"obj":"Sentence"},{"id":"T3","span":{"begin":163,"end":405},"obj":"Sentence"},{"id":"T4","span":{"begin":406,"end":628},"obj":"Sentence"},{"id":"T5","span":{"begin":629,"end":637},"obj":"Sentence"},{"id":"T6","span":{"begin":638,"end":796},"obj":"Sentence"},{"id":"T7","span":{"begin":797,"end":927},"obj":"Sentence"},{"id":"T8","span":{"begin":928,"end":1034},"obj":"Sentence"},{"id":"T9","span":{"begin":1035,"end":1043},"obj":"Sentence"},{"id":"T10","span":{"begin":1044,"end":1214},"obj":"Sentence"},{"id":"T11","span":{"begin":1215,"end":1367},"obj":"Sentence"},{"id":"T12","span":{"begin":1368,"end":1470},"obj":"Sentence"},{"id":"T13","span":{"begin":1471,"end":1556},"obj":"Sentence"},{"id":"T14","span":{"begin":1557,"end":1629},"obj":"Sentence"},{"id":"T15","span":{"begin":1630,"end":1757},"obj":"Sentence"},{"id":"T16","span":{"begin":1758,"end":1770},"obj":"Sentence"},{"id":"T17","span":{"begin":1771,"end":1893},"obj":"Sentence"},{"id":"T18","span":{"begin":1894,"end":2090},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
DisGeNET
{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":87,"end":108},"obj":"gene:3065"},{"id":"T1","span":{"begin":112,"end":149},"obj":"disease:C1168401"},{"id":"T2","span":{"begin":19,"end":31},"obj":"gene:100126343"},{"id":"T3","span":{"begin":112,"end":149},"obj":"disease:C1168401"},{"id":"T4","span":{"begin":241,"end":253},"obj":"gene:100126343"},{"id":"T5","span":{"begin":340,"end":345},"obj":"disease:C1334647"},{"id":"T6","span":{"begin":241,"end":253},"obj":"gene:100126343"},{"id":"T7","span":{"begin":397,"end":404},"obj":"disease:C0006826"},{"id":"T8","span":{"begin":241,"end":253},"obj":"gene:100126343"},{"id":"T9","span":{"begin":299,"end":338},"obj":"disease:C1334647"},{"id":"T10","span":{"begin":255,"end":262},"obj":"gene:100126343"},{"id":"T11","span":{"begin":340,"end":345},"obj":"disease:C1334647"},{"id":"T12","span":{"begin":255,"end":262},"obj":"gene:100126343"},{"id":"T13","span":{"begin":397,"end":404},"obj":"disease:C0006826"},{"id":"T14","span":{"begin":255,"end":262},"obj":"gene:100126343"},{"id":"T15","span":{"begin":299,"end":338},"obj":"disease:C1334647"},{"id":"T16","span":{"begin":524,"end":531},"obj":"gene:100126343"},{"id":"T17","span":{"begin":621,"end":626},"obj":"disease:C1168401"},{"id":"T18","span":{"begin":524,"end":531},"obj":"gene:100126343"},{"id":"T19","span":{"begin":582,"end":619},"obj":"disease:C1168401"},{"id":"T20","span":{"begin":478,"end":485},"obj":"gene:100126343"},{"id":"T21","span":{"begin":621,"end":626},"obj":"disease:C1168401"},{"id":"T22","span":{"begin":478,"end":485},"obj":"gene:100126343"},{"id":"T23","span":{"begin":582,"end":619},"obj":"disease:C1168401"},{"id":"T24","span":{"begin":478,"end":485},"obj":"gene:100126343"},{"id":"T25","span":{"begin":489,"end":495},"obj":"disease:C1306459"},{"id":"T26","span":{"begin":478,"end":485},"obj":"gene:100126343"},{"id":"T27","span":{"begin":489,"end":495},"obj":"disease:C0006826"},{"id":"T28","span":{"begin":782,"end":785},"obj":"gene:6302"},{"id":"T29","span":{"begin":764,"end":769},"obj":"disease:C1168401"},{"id":"T30","span":{"begin":782,"end":785},"obj":"gene:54187"},{"id":"T31","span":{"begin":764,"end":769},"obj":"disease:C1168401"},{"id":"T32","span":{"begin":676,"end":683},"obj":"gene:100126343"},{"id":"T33","span":{"begin":764,"end":769},"obj":"disease:C1168401"},{"id":"T34","span":{"begin":1065,"end":1072},"obj":"gene:100126343"},{"id":"T35","span":{"begin":1109,"end":1114},"obj":"disease:C1168401"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"},{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"},{"id":"R4","pred":"associated_with","subj":"T6","obj":"T7"},{"id":"R5","pred":"associated_with","subj":"T8","obj":"T9"},{"id":"R6","pred":"associated_with","subj":"T10","obj":"T11"},{"id":"R7","pred":"associated_with","subj":"T12","obj":"T13"},{"id":"R8","pred":"associated_with","subj":"T14","obj":"T15"},{"id":"R9","pred":"associated_with","subj":"T16","obj":"T17"},{"id":"R10","pred":"associated_with","subj":"T18","obj":"T19"},{"id":"R11","pred":"associated_with","subj":"T20","obj":"T21"},{"id":"R12","pred":"associated_with","subj":"T22","obj":"T23"},{"id":"R13","pred":"associated_with","subj":"T24","obj":"T25"},{"id":"R14","pred":"associated_with","subj":"T26","obj":"T27"},{"id":"R15","pred":"associated_with","subj":"T28","obj":"T29"},{"id":"R16","pred":"associated_with","subj":"T30","obj":"T31"},{"id":"R17","pred":"associated_with","subj":"T32","obj":"T33"},{"id":"R18","pred":"associated_with","subj":"T34","obj":"T35"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
Allie
{"project":"Allie","denotations":[{"id":"SS1_23558898_2_0","span":{"begin":185,"end":193},"obj":"expanded"},{"id":"SS2_23558898_2_0","span":{"begin":195,"end":200},"obj":"abbr"},{"id":"SS1_23558898_2_1","span":{"begin":241,"end":253},"obj":"expanded"},{"id":"SS2_23558898_2_1","span":{"begin":255,"end":262},"obj":"abbr"},{"id":"SS1_23558898_2_2","span":{"begin":299,"end":338},"obj":"expanded"},{"id":"SS2_23558898_2_2","span":{"begin":340,"end":345},"obj":"abbr"},{"id":"SS1_23558898_3_0","span":{"begin":582,"end":619},"obj":"expanded"},{"id":"SS2_23558898_3_0","span":{"begin":621,"end":626},"obj":"abbr"},{"id":"SS1_23558898_12_0","span":{"begin":1481,"end":1502},"obj":"expanded"},{"id":"SS2_23558898_12_0","span":{"begin":1504,"end":1509},"obj":"abbr"}],"relations":[{"id":"AE1_23558898_2_0","pred":"abbreviatedTo","subj":"SS1_23558898_2_0","obj":"SS2_23558898_2_0"},{"id":"AE1_23558898_2_1","pred":"abbreviatedTo","subj":"SS1_23558898_2_1","obj":"SS2_23558898_2_1"},{"id":"AE1_23558898_2_2","pred":"abbreviatedTo","subj":"SS1_23558898_2_2","obj":"SS2_23558898_2_2"},{"id":"AE1_23558898_3_0","pred":"abbreviatedTo","subj":"SS1_23558898_3_0","obj":"SS2_23558898_3_0"},{"id":"AE1_23558898_12_0","pred":"abbreviatedTo","subj":"SS1_23558898_12_0","obj":"SS2_23558898_12_0"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
PubmedHPO
{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":315,"end":338},"obj":"HP_0002860"},{"id":"T2","span":{"begin":363,"end":369},"obj":"HP_0002664"},{"id":"T3","span":{"begin":397,"end":404},"obj":"HP_0002664"},{"id":"T4","span":{"begin":489,"end":495},"obj":"HP_0002664"},{"id":"T5","span":{"begin":541,"end":547},"obj":"HP_0002664"},{"id":"T6","span":{"begin":596,"end":619},"obj":"HP_0002860"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
DisGeNET5_gene_disease
{"project":"DisGeNET5_gene_disease","denotations":[{"id":"23558898-0#19#31#gene100126343","span":{"begin":19,"end":31},"obj":"gene100126343"},{"id":"23558898-0#87#108#gene3065","span":{"begin":87,"end":108},"obj":"gene3065"},{"id":"23558898-0#112#149#diseaseC1168401","span":{"begin":112,"end":149},"obj":"diseaseC1168401"},{"id":"23558898-1#78#90#gene100126343","span":{"begin":241,"end":253},"obj":"gene100126343"},{"id":"23558898-1#92#99#gene100126343","span":{"begin":255,"end":262},"obj":"gene100126343"},{"id":"23558898-1#136#175#diseaseC1334647","span":{"begin":299,"end":338},"obj":"diseaseC1334647"},{"id":"23558898-1#177#182#diseaseC1334647","span":{"begin":340,"end":345},"obj":"diseaseC1334647"},{"id":"23558898-1#136#175#diseaseC1334647","span":{"begin":299,"end":338},"obj":"diseaseC1334647"},{"id":"23558898-1#177#182#diseaseC1334647","span":{"begin":340,"end":345},"obj":"diseaseC1334647"},{"id":"23558898-12#76#93#gene7248","span":{"begin":1847,"end":1864},"obj":"gene7248"},{"id":"23558898-12#50#55#diseaseC1168401","span":{"begin":1821,"end":1826},"obj":"diseaseC1168401"},{"id":"23558898-3#144#147#gene54187","span":{"begin":782,"end":785},"obj":"gene54187"},{"id":"23558898-3#144#147#gene6302","span":{"begin":782,"end":785},"obj":"gene6302"},{"id":"23558898-3#126#131#diseaseC1168401","span":{"begin":764,"end":769},"obj":"diseaseC1168401"}],"relations":[{"id":"19#31#gene100126343112#149#diseaseC1168401","pred":"associated_with","subj":"23558898-0#19#31#gene100126343","obj":"23558898-0#112#149#diseaseC1168401"},{"id":"87#108#gene3065112#149#diseaseC1168401","pred":"associated_with","subj":"23558898-0#87#108#gene3065","obj":"23558898-0#112#149#diseaseC1168401"},{"id":"78#90#gene100126343136#175#diseaseC1334647","pred":"associated_with","subj":"23558898-1#78#90#gene100126343","obj":"23558898-1#136#175#diseaseC1334647"},{"id":"78#90#gene100126343177#182#diseaseC1334647","pred":"associated_with","subj":"23558898-1#78#90#gene100126343","obj":"23558898-1#177#182#diseaseC1334647"},{"id":"78#90#gene100126343136#175#diseaseC1334647","pred":"associated_with","subj":"23558898-1#78#90#gene100126343","obj":"23558898-1#136#175#diseaseC1334647"},{"id":"78#90#gene100126343177#182#diseaseC1334647","pred":"associated_with","subj":"23558898-1#78#90#gene100126343","obj":"23558898-1#177#182#diseaseC1334647"},{"id":"92#99#gene100126343136#175#diseaseC1334647","pred":"associated_with","subj":"23558898-1#92#99#gene100126343","obj":"23558898-1#136#175#diseaseC1334647"},{"id":"92#99#gene100126343177#182#diseaseC1334647","pred":"associated_with","subj":"23558898-1#92#99#gene100126343","obj":"23558898-1#177#182#diseaseC1334647"},{"id":"92#99#gene100126343136#175#diseaseC1334647","pred":"associated_with","subj":"23558898-1#92#99#gene100126343","obj":"23558898-1#136#175#diseaseC1334647"},{"id":"92#99#gene100126343177#182#diseaseC1334647","pred":"associated_with","subj":"23558898-1#92#99#gene100126343","obj":"23558898-1#177#182#diseaseC1334647"},{"id":"76#93#gene724850#55#diseaseC1168401","pred":"associated_with","subj":"23558898-12#76#93#gene7248","obj":"23558898-12#50#55#diseaseC1168401"},{"id":"144#147#gene54187126#131#diseaseC1168401","pred":"associated_with","subj":"23558898-3#144#147#gene54187","obj":"23558898-3#126#131#diseaseC1168401"},{"id":"144#147#gene6302126#131#diseaseC1168401","pred":"associated_with","subj":"23558898-3#144#147#gene6302","obj":"23558898-3#126#131#diseaseC1168401"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
DisGeNet-2017-sample
{"project":"DisGeNet-2017-sample","denotations":[{"id":"T2678","span":{"begin":782,"end":785},"obj":"gene:54187"},{"id":"T2679","span":{"begin":764,"end":769},"obj":"disease:C1168401"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T2678","obj":"T2679"},{"id":"R2","pred":"associated_with","subj":"T2678","obj":"T2679"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
UBERON-AE
{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":112,"end":116},"obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":582,"end":586},"obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"id":"PD-UBERON-AE-B_T3","span":{"begin":121,"end":125},"obj":"http://purl.obolibrary.org/obo/UBERON_0000974"},{"id":"PD-UBERON-AE-B_T4","span":{"begin":591,"end":595},"obj":"http://purl.obolibrary.org/obo/UBERON_0000974"},{"id":"PD-UBERON-AE-B_T5","span":{"begin":299,"end":314},"obj":"http://purl.obolibrary.org/obo/UBERON_0001764"},{"id":"PD-UBERON-AE-B_T6","span":{"begin":1115,"end":1122},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}
performance-test
{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":1115,"end":1122},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"PD-UBERON-AE-B_T2","span":{"begin":112,"end":116},"obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"id":"PD-UBERON-AE-B_T3","span":{"begin":582,"end":586},"obj":"http://purl.obolibrary.org/obo/UBERON_0000033"},{"id":"PD-UBERON-AE-B_T4","span":{"begin":121,"end":125},"obj":"http://purl.obolibrary.org/obo/UBERON_0000974"},{"id":"PD-UBERON-AE-B_T5","span":{"begin":591,"end":595},"obj":"http://purl.obolibrary.org/obo/UBERON_0000974"},{"id":"PD-UBERON-AE-B_T6","span":{"begin":299,"end":314},"obj":"http://purl.obolibrary.org/obo/UBERON_0001764"}],"text":"Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.\nBACKGROUND: Our recent studies of microRNA (miRNA) expression signature demonstrated that microRNA-874 (miR-874) was significantly downregulated in maxillary sinus squamous cell carcinoma (MSSCC), and a putative tumour-suppressive miRNA in human cancers. Our aim of this study was to investigate the functional significance of miR-874 in cancer cells and to identify novel miR-874-mediated cancer pathways and responsible genes in head and neck squamous cell carcinoma (HNSCC).\nMETHODS: Gain-of-function studies using mature miR-874 were performed to investigate cell proliferation and cell cycle distribution in HNSCC cell lines (SAS and FaDu). To identify miR-874-mediated molecular pathways and targets, we utilised gene expression analysis and in silico database analysis. Loss-of-function assays were performed to investigate the functional significance of miR-874 target genes.\nRESULTS: Expression levels of miR-874 were significantly downregulated in HNSCC tissues (including oral, pharyngeal and laryngeal SCCs) compared with normal counterpart epithelia. Restoration of miR-874 in SAS and FaDu cell lines revealed significant inhibition of cell proliferation and induction of G2/M arrest and cell apoptosis. Our expression data and in silico analysis demonstrated that miR-874 modulated the cell cycle pathway. Moreover, histone deacetylase 1 (HDAC1) was a candidate target of miR-874 regulation. Luciferase reporter assays showed that miR-874 directly regulated HDAC1. Silencing of the HDAC1 gene significantly inhibited cell proliferation and induced G2/M arrest and cell apoptosis in SAS cells.\nCONCLUSIONS: Downregulation of miR-874 was a frequent event in HNSCC. miR-874 acted as a tumour suppressor and directly targeted HDAC1. Recognition of tumour-suppressive miRNA-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis and suggests novel therapeutic strategies for the disease."}